July Stock Themes: SEBI RA Rohit Mehta Flags Renewables, Pharma, Infra Sectors For Big Rotations

India’s renewable energy, pharmaceutical, and infrastructure sectors are gaining investor attention heading into July, driven by structural growth drivers such as government incentives, global demand, and a stable policy environment.

SEBI-registered analyst Rohit Mehta said smart money is rotating into these three sectors, driven by long-term fundamentals. 

In renewable energy, Mehta cited India’s ₹24,000 crore PLI scheme for solar modules, rising domestic installations toward the 175+ GW 2030 target, and global deals like Waaree Solar Americas’ 540 MW order. 

He flagged Waaree Energies, Inox Wind, Servotech Power, and KPI Green Energy as key stocks to watch.

In pharma, Mehta noted a shift from low-margin generics to high-value contract research and manufacturing services (CRAMS), contract development and manufacturing organizations (CDMO), and biosimilars, driven by the China+1 strategy and increased production-linked incentive (PLI) support. 

Suven Pharma, Divi’s Labs, Biocon, Neuland Labs, and Syngene were highlighted for their strong positioning.

On infrastructure, Mehta pointed to ₹11 lakh crore in capital expenditure plans in the FY26 Budget and continued momentum in railways, metros, defense, and electrification. 

He named L&T, IRB Infra, KEC International, KNR Construction, Ahluwalia Contracts, Polycab, and KEI Industries as top beneficiaries.

For updates and corrections, email newsroom[at]stocktwits[dot]com.